Association of Apolipoprotein L-1 polymorphisms with blood pressure in three multi-ethnic African studies by Shuchi Anand, Safa Abdalla, Gladwell Gathecha, Olulola O Oladapo, Kibachio Joseph, Maria E Montez-Rath, Marcella Aslan, Michele Barry, Glenn M Chertow, Charles Rotimi, David J Friedman

Connect to this object online.

Point-of-Care Testing in Chronic Kidney Disease of Non-Traditional Origin: Considerations for Clinical, Epidemiological, and Health Surveillance Research and Practice by Miranda Dally, Juan José Amador, Jaime Butler-Dawson, Damaris Lopez-Pilarte, Alexandra Gero, Lyndsay Krisher, Alex Cruz, Daniel Pilloni, Joseph Kupferman, David J. Friedman, Benjamin R. Griffin, Lee S. Newman, Daniel R. Brooks

Connect to this object online.

COVID-19 and CKD: Employment, Food Security and Healthcare in El Salvador by Jessica H. Leibler, Sinead A. Keogh, Emmanuel Jarquín, Ramon Garcia-Trabanino, Juan José Amador Velázquez, Damaris Lopez Pilarte, Marvin Beltran, Iris S. Delgado, Zoe E. Petropoulos, David J. Friedman, Daniel R. Brooks, Madeleine K. Scammell

Connect to this object online.

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease by Gizelle M. McCarthy, Angelo Blasio, Olivia G. Donovan, Lena B. Schaller, Althea Bock-Hughes, Jose M. Magraner, Jung Hee Suh, Calum F. Tattersfield, Isaac E. Stillman, Shrijal S. Shah, Zsuzsanna K. Zsengeller, Balajikarthick Subramanian, David J. Friedman, Martin R. Pollak

Connect to this object online.